Profile
Corporate information
Official name
Blossomhill Therapeutics, Inc.
Registration country
Official name
Blossomhill Therapeutics, Inc.
Registration country
Investment activity status
Active investor
Company type
Biotechnology company focused on oncology and autoimmune disorders.Funding
Funding rounds
Series A USD 71,000,000
USD 71,000,000 (4 Mar 2021)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Cormorant Asset Management LLC | Initial investment. Led the round. | ||
|
Hercules BioVentures | Initial investment. Round participant. | ||
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States | Initial investment. Round participant. |
|
Vivo Capital LLC | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Cormorant Asset Management LLC |
Series A | |
|
|
Hercules BioVentures |
Series A | |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
Series A |
|
|
Vivo Capital LLC |
Series A |